CorMedix (CRMD) Share-based Compensation Growth (3y) (2015 - 2025)
CorMedix (CRMD) Share-based Compensation Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 60.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 60.13% |
| Sep 30, 2025 | 49.71% |
| Jun 30, 2025 | 276.90% |
| Mar 31, 2025 | 65.67% |
| Dec 31, 2024 | -33.80% |
| Sep 30, 2024 | 5.41% |
| Jun 30, 2024 | 7.76% |
| Mar 31, 2024 | -61.72% |
| Dec 31, 2023 | -68.66% |
| Sep 30, 2023 | -35.39% |
| Jun 30, 2023 | -35.17% |
| Mar 31, 2023 | 48.51% |
| Dec 31, 2022 | 24.46% |
| Sep 30, 2022 | -29.19% |
| Jun 30, 2022 | -72.93% |
| Mar 31, 2022 | 12.04% |
| Dec 31, 2021 | 286.82% |
| Sep 30, 2021 | 45.68% |
| Jun 30, 2021 | 44.18% |
| Mar 31, 2021 | 70.40% |